title: Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
authors.affiliation: Dept. of Surgery, Cooper Hospital/University Medical Center, Camden, NJ 08103.
authors.forename: R K
authors.initials: RK
authors.lastname: Spence
authors.forename: S
authors.initials: S
authors.lastname: McCoy
authors.forename: J
authors.initials: J
authors.lastname: Costabile
authors.forename: E D
authors.initials: ED
authors.lastname: Norcross
authors.forename: M
authors.initials: M
authors.lastname: Pello
authors.forename: J
authors.initials: J
authors.lastname: Alexander
authors.forename: U
authors.initials: U
authors.lastname: Atabek
authors.forename: C
authors.initials: C
authors.lastname: Wisdom
authors.forename: R
authors.initials: R
authors.lastname: Camishion
mesh_terms: D000740:Anemia / Q000097:blood / Q000628:therapy*; D001802:Blood Substitutes / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D005466:Fluorocarbons / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D010100:Oxygen / Q000097:blood
chemical_list: D001802:Blood Substitutes; D004338:Drug Combinations; D005466:Fluorocarbons; D006895:Hydroxyethyl Starch Derivatives; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination; D010100:Oxygen